Almost a decade after they were first proven to be safe and highly effective, game-changing medicines to cure hepatitis C are becoming more widely available in South Africa. But not all the regulatory and other challenges behind the delay have been overcome, and access remains relatively limite.
A round-table discussion is taking place on initiatives needed to slow the transmission and death rate of hepatitis in Africa, and the Alternative Information and Development Centre, the Centre for Applied Legal Studies and Lawyers for Human Rights are holding a two-day indaba on the ‘UN Bind.